iPierian

Developer of therapies designed to treat neurodegenerative disease. The company engages in the research and development of therapies and monoclonal antibodies for treating Alzheimer's disease and other Tauopathies, enabling physicians to slow the spread of Tau throughout the brain and therefore inhibit the associated disease progression.

Kleiner Perkins

🏥 Healthcare